NASDAQ: HCSG

HEALTHCARE SERVICES GROUP INC

CIK 0000731012 · SIC 8050 · Nursing & Personal Care Facilities

Mid Revenue $1.8B Assets $821M as of Oct 18, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (AAL 10-Q) is open in full — no account needed.

10-Q Filed Oct 23, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Oct 21, 2026 · Period ending Oct 21, 2026

Summary not yet generated.

Partner

Trade HCSG commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Oct 7, 2026 · Period ending Oct 6, 2026

Healthcare Services Group to acquire NEXDINE Hospitality for $93.5M, adding $150M+ revenue

4 material changes detected. Sign up free to read the summary.

View report
10-Q Filed Jul 24, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jul 22, 2026 · Period ending Jul 22, 2026

Summary not yet generated.

8-K Filed May 27, 2026 · Period ending May 26, 2026

Summary not yet generated.

10-Q Filed Apr 24, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed Apr 22, 2026 · Period ending Apr 22, 2026

Summary not yet generated.

10-K Filed Feb 13, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Oct 24, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K Filed Feb 14, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 23, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Comprehensive Income (Unaudited)

(in thousands, except per share amounts)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Revenues 479,604 464,338 1,413,178 1,370,491
Operating costs and expenses:
Costs of services provided 399,215 367,933 1,182,161 1,203,157
Selling, general and administrative 48,452 50,541 143,034 144,670
Other income (expense):
Investment and other income, net 2,109 11,837 12,591 17,856
Interest expense (318) (393) (1,302) (1,206)
Income before taxes 33,728 57,308 99,272 39,314
Income tax provision 8,851 14,355 25,639 11,499
Net income 24,877 42,953 73,633 27,815
Per share data:
Basic earnings per common share 0.37 0.59 1.07 0.38
Diluted earnings per common share 0.36 0.59 1.05 0.38
Weighted average number of common shares outstanding:
Basic 68,005 72,237 68,873 73,019
Diluted 69,379 72,966 70,110 73,505
Comprehensive income:
Net income 24,877 42,953 73,633 27,815
Other comprehensive income
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes (2,422) 713 (2,912) 1,588
Total comprehensive income 22,455 43,666 70,721 29,403

Consolidated Balance Sheets (Unaudited)

(in thousands, except per share amounts)

Description September 30, 2026 (unaudited) December 31, 2025
Current assets:
Cash and cash equivalents 134,598 125,189
Restricted cash equivalents 115 5,577
Marketable securities, at fair value 34,223 42,774
Restricted marketable securities, at fair value 35,367 30,352
Accounts receivable, net (less allowances: $113,917 and $119,305) 309,595 281,303
Notes receivable short–term portion, net (less allowances: $25,022 and $25,931) 24,504 31,243
Inventories and supplies 15,533 16,797
Taxes receivable — 22,246
Prepaid expenses and other current assets 28,826 20,934
Total current assets 582,761 576,415
Property and equipment, net 30,777 27,586
Goodwill 90,456 79,797
Other intangible assets (less accumulated amortization of $45,264 and $42,931) 16,860 6,964
Notes receivable long–term portion, net (less allowances: $2,924 and $1,776) 42,350 25,209
Deferred compensation funding, at fair value 59,018 55,909
Deferred tax assets 18,639 18,472
Other long-term assets 9,537 3,901
Total assets 850,398 794,253
LIABILITIES AND STOCKHOLDERS’ EQUITY:
Current liabilities:
Accounts payable 92,170 77,382
Accrued payroll and related taxes 54,661 31,400
Other accrued expenses and current liabilities 36,505 37,222
Taxes payable 1,733 —
Accrued insurance claims 21,353 24,371
Total current liabilities 206,422 170,375
Accrued insurance claims long-term 41,156 46,142
Deferred compensation liability long-term 59,122 56,276
Lease liability long-term 11,433 9,659
Other long-term liabilities 814 1,591
Commitments and contingencies (Note 17)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 200,000 shares authorized; 77,300 and 76,821 shares issued, and 67,432 and 69,596 shares outstanding 773 768
Additional paid-in capital 334,296 327,956
Retained earnings 357,304 283,668
Accumulated other comprehensive loss, net of taxes (3,360) (448)
Common stock in treasury, at cost, 9,868 and 7,225 shares (157,562) (101,734)
Total stockholders’ equity 531,451 510,210
Total liabilities and stockholders’ equity 850,398 794,253

Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Cash flows from operating activities:
Net income 73,633 27,815
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization 11,382 12,908
Bad debt provision 4,455 79,012
Deferred income taxes 606 15,939
Share-based compensation expense 8,527 8,881
Accretion of discounts/amortization of premium on marketable securities, net (21) 359
Unrealized gain on deferred compensation fund investments (4,789) (6,926)
Changes in other long-term assets and liabilities 814 (384)
Net loss on disposals of property and equipment 313 253
Share of losses from equity method investment 92 2,386
Changes in operating assets and liabilities:
Accounts and notes receivable (41,504) 5,255
Inventories and supplies 1,261 (453)
Prepaid expenses and other assets (8,778) (3,603)
Deferred compensation funding 1,438 469
Accounts payable and other accrued expenses 5,080 (5,310)
Accrued payroll and related taxes 23,786 (134)
Deferred ERC credits — 12,276
Taxes receivable/payable 23,979 (23,953)
Accrued insurance claims (8,035) (4,115)
Deferred compensation liability 3,531 6,906
Net cash from operating activities 95,770 127,581
Cash flows from investing activities:
Disposals of property and equipment 160 86
Additions to property and equipment (5,097) (4,438)
Cash paid for acquisitions, net of cash acquired (22,858) (7,287)
Cash paid for equity investments (4,625) (2,125)
Purchases of marketable securities (21,345) (13,884)
Sales of marketable securities 21,242 8,082
Net cash from investing activities (32,523) (19,566)
Cash flows from financing activities:
Purchases of treasury stock (56,628) (41,982)
Payments of statutory withholding on net issuance of restricted stock units (4,162) (1,744)
Proceeds from the exercise of stock options 1,490 —
Net cash from financing activities (59,300) (43,726)
Net increase in cash, cash equivalents and restricted cash equivalents 3,947 64,289
Cash, cash equivalents and restricted cash equivalents at beginning of the period 130,766 60,131
Cash, cash equivalents and restricted cash equivalents at end of the period 134,713 124,420

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View all filings for HCSG on SEC EDGAR